BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35636357)

  • 21. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks.
    Jemaa S; Fredrickson J; Carano RAD; Nielsen T; de Crespigny A; Bengtsson T
    J Digit Imaging; 2020 Aug; 33(4):888-894. PubMed ID: 32378059
    [No Abstract]   [Full Text] [Related]  

  • 24. Deep learning-based attenuation correction for whole-body PET - a multi-tracer study with
    Toyonaga T; Shao D; Shi L; Zhang J; Revilla EM; Menard D; Ankrah J; Hirata K; Chen MK; Onofrey JA; Lu Y
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3086-3097. PubMed ID: 35277742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semi-automated histogram analysis of normal bone marrow using
    Satoh Y; Funayama S; Onishi H; Kirito K
    BMC Med Imaging; 2022 Feb; 22(1):31. PubMed ID: 35197004
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
    Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated lung cancer assessment on 18F-PET/CT using Retina U-Net and anatomical region segmentation.
    Weikert T; Jaeger PF; Yang S; Baumgartner M; Breit HC; Winkel DJ; Sommer G; Stieltjes B; Thaiss W; Bremerich J; Maier-Hein KH; Sauter AW
    Eur Radiol; 2023 Jun; 33(6):4270-4279. PubMed ID: 36625882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis.
    Yousefirizi F; Klyuzhin IS; O JH; Harsini S; Tie X; Shiri I; Shin M; Lee C; Cho SY; Bradshaw TJ; Zaidi H; Bénard F; Sehn LH; Savage KJ; Steidl C; Uribe CF; Rahmim A
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1937-1954. PubMed ID: 38326655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does whole-body Patlak
    Fahrni G; Karakatsanis NA; Di Domenicantonio G; Garibotto V; Zaidi H
    Eur Radiol; 2019 Sep; 29(9):4812-4821. PubMed ID: 30689031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal studies of the
    Sachpekidis C; Anwar H; Winkler JK; Kopp-Schneider A; Larribere L; Haberkorn U; Hassel JC; Dimitrakopoulou-Strauss A
    Cancer Immunol Immunother; 2018 Aug; 67(8):1261-1270. PubMed ID: 29872898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
    J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of manual and automated approaches for segmentation and extraction of quantitative indices from [
    Krokos G; Kotwal T; Malaih A; Barrington S; Jackson P; Hicks RJ; Marsden PK; Fischer BM
    Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38100790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated measurement of uptake in cerebellum, liver, and aortic arch in full-body FDG PET/CT scans.
    Bauer C; Sun S; Sun W; Otis J; Wallace A; Smith BJ; Sunderland JJ; Graham MM; Sonka M; Buatti JM; Beichel RR
    Med Phys; 2012 Jun; 39(6):3112-23. PubMed ID: 22755696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.
    Cafagna D; Rubini G; Iuele F; Maggialetti N; Notaristefano A; Pinto D; Niccoli-Asabella A; Palmiotti G; Lasciarrea M; Maggialetti A
    Radiol Med; 2012 Mar; 117(2):293-311. PubMed ID: 21744252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Value of
    Hynninen J; Laasik M; Vallius T; Kemppainen J; Grönroos S; Virtanen J; Casado J; Hautaniemi S; Grenman S; Seppänen M; Auranen A
    Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):507-514. PubMed ID: 29753662
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Ito K; Teng R; Schöder H; Humm JL; Ni A; Michaud L; Nakajima R; Yamashita R; Wolchok JD; Weber WA
    J Nucl Med; 2019 Mar; 60(3):335-341. PubMed ID: 30413661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from
    Schmidkonz C; Krumbholz M; Atzinger A; Cordes M; Goetz TI; Prante O; Ritt P; Schaefer C; Agaimy A; Hartmann W; Rössig C; Fröhlich B; Bäuerle T; Dirksen U; Kuwert T; Metzler M
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1564-1575. PubMed ID: 31853559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automatic detection of primary and metastatic lesions on cervicothoracic region and whole-body bone using a uniform machine-learnable approach for [18F]-FDG-PET/CT image analysis.
    Nemoto M; Tanaka A; Kaida H; Kimura Y; Nagaoka T; Yamada T; Hanaoka K; Kitajima K; Tsuchitani T; Ishii K
    Phys Med Biol; 2022 Sep; 67(19):. PubMed ID: 36096113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.